Abstract
Researchers are looking for a way to prevent cytomegalovirus (CMV) in children and adolescents who receive a kidney transplant (KT) and weigh less than 40 kilograms (88.2 pounds). The goals of the study are to:
Learn what happens to letermovir in the body over time
Learn about the safety of letermovir and if participants tolerate it
